Kanoun, Rimmel Yosra, et al. “Role of Measurable Residual Disease Quantified by 4 to 6 Color Flow Cytometry before Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Philadelphia-Negative Acute Lymphoblastic Leukemia”. Journal of Stem Cell Therapy and Transplantation, vol. 7, no. 1, Apr. 2023, pp. 016-23, doi:10.29328/journal.jsctt.1001031.